CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass. NeuroPass is a fully implantable, skull-embedded platform. The Baltimore-based company designed it to bypass the blood-brain barrier (BBB). It could enable targeted drug delivery and monitoring in the brain. CraniUS has NeuroPass under development […]
